Table 2.
Summary table of all monkeypox cases highlighting demographic, symptoms, management, and outcomes.
| Variables | n/N (%) |
|---|---|
| N | 1078 |
| Age (mean, SD) | 20.66 ± 16.45 years |
| Male, n (%) | 583 [54%] |
| Female, n (%) | 489 [46%] |
| NR | 6 |
| Country | |
| UK | 2/10 [20%] |
| Nigeria | 1/10 [10%] |
| Sierra Leone | 1/10 [10%] |
| DR Congo | 3/10 [30%] |
| Singapore | 1/10 [10%] |
| USA | 1/10 [10%] |
| Australia | 1/10 [10%] |
| Monkeypox viral DNA test | RT PCR: 1074/1075 [99.9%] |
| Symptoms | |
| Fever | 1037/1047 [99%] |
| Headache | 797/1021 [78%] |
| Lymphadenopathy |
886/1047 [85%] [cervical lymphadenopathy is most common] |
| Upper respiratory symptoms | 563/1027 [55%] |
| Rash | 1078/1078 [100%] |
| Oral ulcers | 570/1018 [56%] |
| Vomiting | 251/1012 [25%] |
| Conjunctivitis | 211/1017 [21%] |
| Management | |
| Antivirals | 7/11 [63%] |
| Antibiotics | 4/10[40%] |
| Length of hospitalization (mean) | 13.3 ± 6.37 days |
| Duration of management (mean) | 5 days |
| Outcomes |
Recovery‐ 19/20 [95%] Death: 1/20 [5%] |